Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells

The majority of triple-negative breast cancers (TNBCs) are basal-like breast cancers. However there is no reported study on anti-tumor effects of sunitinib in xenografts of basal-like TNBC (MDA-MB-468) cells. In the present study, MDA-MB-231, MDA-MB-468, MCF-7 cells were cultured using RPMI 1640 med...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Chinchar, Edmund, Makey, Kristina L, Gibson, John, Chen, Fang, Cole, Shelby A, Megason, Gail C, Vijayakumar, Srinivassan, Miele, Lucio, Gu, Jian-Wei
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4049452/
https://ncbi.nlm.nih.gov/pubmed/24914410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-824X-6-12
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items